Clinical trial
CF Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CF Leukocyte Genes as Biomarkers for Novel Therapies
- Lead sponsor
- National Jewish Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- October 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis, pulmonary exacerbation